Comprehensive biomarkers
Quantitative EEG, P300 evoked potentials, plasma biomarkers of brain injury and neuroinflammation. MR volumetry, retinal OCT, genetic screening and an objective map of disease risk and early brain ageing.
Brain-health continuum · PROTECT level
Alzheimer's and Parkinson's disease begins 15–20 years before the first complaints. Vascular damage to the brain — even earlier. PROTECT finds these changes while they can still be influenced.
The centre's medical and scientific director and the author of the programme is Dr. Viktor Kholin, a European expert in neurodegenerative disease, ageing neurology and brain longevity with 25 years of experience.
How it works
PROTECT is a year-round loop, not a one-off check-up. We measure the state of your brain, find your risk factors, act on them, and a year later repeat the measurement with the same battery. That shows the direction of travel, not a single point.
qEEG, plasma biomarkers, cognitive profile. A baseline in numbers, from which everything else is counted.
Blood pressure, glucose, sleep, hearing, physical activity, mood. We show which factors you have and how much each one weighs.
The medical board draws up a year plan with priorities: where to start and what will give you the greatest effect.
TPS and micropolarisation under supervision, plus lifestyle correction.
Repeat markers — catching shifts early, before symptoms. The same battery, so changes are seen reliably.
The protocol is reviewed by the data, not by the calendar. Whatever isn't working, we drop.
Quick test
Five short questions, one minute — see what state your brain is in and what to do next. No sign-up, results right away.
What PROTECT gives you
Decades pass between the first molecular event and the first noticeable symptom. All that time the brain compensates for damage out of its reserve — and outwardly the person is healthy. When the reserve runs out, symptoms appear at once, already against a background of significant accumulated damage. That is why intervening before symptoms gives a fundamentally greater effect.
The most valuable window is the years before the first signs. Early prevention preserves the brain rather than compensating for loss.
Hypertension, diabetes, sleep disorders, hearing loss, physical inactivity, depression — factors with a proven contribution to dementia. They can be influenced, and PROTECT shows which of them you have.
One report: a brain-health index, your biological brain age against your calendar age, the volume of cerebral reserve and a plan for the year. Not a stack of forms, but a single document with numbers.
Assess your risk and build a plan. You will get your position on the continuum in numbers and the list of factors you should start with.
Methods
We don't choose between "blood" and "scans". Assessment runs simultaneously at the molecular, structural and functional levels — and the divergence between them is itself diagnostically meaningful. Every method is matched to your risk profile.
Quantitative EEG, P300 evoked potentials, plasma biomarkers of brain injury and neuroinflammation. MR volumetry, retinal OCT, genetic screening and an objective map of disease risk and early brain ageing.
Transcranial pulse stimulation to support neural networks and build cognitive reserve.
A personal programme correcting vascular, inflammatory and metabolic factors.
Questions
Because the neurodegenerative process begins 15–20 years before the first symptoms, and vascular damage to the brain even earlier. During this period intervention gives the greatest effect, and once symptoms appear it is far smaller. PROTECT exists precisely for this window.
That is your decision, and we respect it. But it is worth understanding that information about risk is needed not for the knowledge itself but for the time: a significant part of the factors is manageable precisely at the asymptomatic stage. Later that resource disappears.
If there are no complaints and no family history — after 35–40. With Alzheimer's, dementia or Parkinson's in your parents, or with vascular risk factors — earlier still.
No. Your decision is enough.
It depends on the scope you choose. The baseline level is one visit. Extended programmes are several visits over one to two weeks. Exact timing is known after the first consultation.
No. The scope is set by the task and the level of programme chosen. The express test gives a preliminary guide; the doctor determines the final set at the consultation — including ruling out what has already been done and is still valid.
Yes. We assess whether they are usable: the method, how recent they are and their completeness matter. Valid, current studies are counted and not duplicated.
One report, not a set of forms. It contains: a brain-health index, your biological brain age compared with your calendar age, a domain profile of cognitive function, separately calculated vascular and neurodegenerative risk, an assessment of cerebral reserve and a personal plan for the year with priorities.
Next comes a clarifying stage and a programme. Some findings concern modifiable factors and are corrected without specific treatment. Some require monitoring. Some mean referral to a specialised clinic. Either way, you leave with a plan, not with anxiety.
The standard interval is one year. With detected abnormalities or active correction of risk factors — sooner, at our specialists' decision. The repeat assessment uses the same battery: without that, the dynamics are unreliable.
Booking
Leave your contact details — a manager will confirm the details and offer the nearest available time.